Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 224-518-3 | CAS number: 4394-85-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2011-06-15 to 2011-06-29 (exp. period)
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline Study OECD 429 and GLP compliance
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 011
- Report date:
- 2011
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- 4-morpholinecarbaldehyde
- EC Number:
- 224-518-3
- EC Name:
- 4-morpholinecarbaldehyde
- Cas Number:
- 4394-85-8
- Molecular formula:
- C5H9NO2
- IUPAC Name:
- morpholine-4-carbaldehyde
- Details on test material:
- - Name of the test material (as cited in the study report): N-Formylmorpholin
- CAS-No.: 4394-85-8
- Appearance: colorless, clear liquid
- Batch No.: O 2891
- Purity: 99.96 area % (corrected for water content, GC analysis)
- Homogeneity: The test substance appeared to be homogeneous.
- Stability in Solvent: Not indicated
- Storage: At room temperature
- Expiration Date: May 16, 2013
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- other: CBA/CaOlaHsd
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan Laboratories B.V., Postbus 6174, 5960 AD Horst, Netherlands
- Age at study initiation: 9-10 weeks old
- Weight at study initiation: 17.5 - 21.1 g
- Housing: Single (pre-test); Group (main study)
- Diet: Pelleted standard diet, ad libitum
- Water: tap water, ad libitum
- Acclimation period: At least 5 days prior to the start of dosing under test conditions after health examination. Only animals without any visible signs of illness were used for the study
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 2
- Humidity (%): 45 - 65
- Air changes (per hr):
- Photoperiod (hrs dark / hrs light): 12/12
Study design: in vivo (LLNA)
- Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 1) 25 %
2) 50 %
3) 100 % - No. of animals per dose:
- 5 mice
- Details on study design:
- RANGE FINDING TEST
For concentration selection one mouse was treated at 75% in acetone olive oil (4:1 v/v) and a second mouse was treated at 100 % (undiluted) for 3 consecutive days. Signs of systemic toxicity, body weights, ear weights, ear thicknuess abd ear erythema were assessed.
- Compound solubility: soluble in acetone olive oil (4:1 v/v)
- Irritation: both animals showed very slight to well defined eryhema with an increase in ear swelling. Undiluted test item (100 %) was selected as highest concentration for the main study as it did neither induce signs of systemic toxicity nor exessive skin irritation.
MAIN STUDY
Each test group of mice was treated by topical (epidermal) application to the dorsal surface of each ear with test item concentrations of 25 %, 50 % (v/v), and 100 % of the undiluted test item in acetone:olive oil (4+1 v/v). The application volume, 25 µL/ear/day, was spread over the entire dorsal surface of each ear once daily for three consecutive days. A further group of mice (control animals) was treated with an equivalent volume of the relevant vehicle alone.
Five days after the first topical application (day 6) 250 µL of phosphate-buffered saline (PBS) containing 20.5 µCi of 3HTdR (equivalent to approximately 82.0 µCi/mL 3HTdR) were injected into each test and control mouse via the tail vein.
Approximately five hours after treatment with 3HTdR all mice were euthanised by intraperitoneal injection of Pentobarbital-Natrium. The draining lymph nodes were rapidly excised and pooled for each animal (2 nodes per animal). Single cell suspensions of pooled lymph node cells were prepared and after several washing steps the level of 3HTdR incorporation was measured using a beta-scitillation counter.
Furthermore, the lymph node cell count was determined.
After the lymph nodes were excised, both ears of all mice were punched at the apical area using a biopsy punch. For each animal both punches were immediately weighed (pooled per animal) using an analytical balance.
In addition 3HTdR incorporation, lymph node weights, lymph node cell count, ear weights and ear thickness, the mortality and clinical signs of toxicity were assessed in this study. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- The mean values and standard deviations were calculated for body weight and for the radioactive disintegrations per minute (DPM) values (group mean DPM ± standard deviation) as well as for the ear weights, lymph node weights and lymph node cell counts.
Statistical analysis was conducted to assess whether the difference was statistically significant between test groups and negative control group.
The EC3 value was calculated according to the equation
EC3 = (a-c) [(3-d)/(b-d)] + c
where EC3 is the estimated concentration of the test item required to produce a 3-fold increase in draining lymph node cell proliferative activity.
For all statistical calculations SigmaStat for Windows (Version 2.0) was used. A One-Way-Analysis-of-Variance (One-Way-ANAOVA) was used as statistical method.
In case of significant results of the One-Way-ANOVA, multiple comparisons were performed with the Dunnett test or Dunn’s test. Statistical significance was set at the 5 %t level (p < 0.05). The Dean-Dixon-Test was used for identification of possible outliers.
Also, the ANOVA (Dunnett-test) was conducted on the ear weights, the lymph node weights and the lymph node cell count to assess whether the difference was statistically significant between test item groups and negative control (vehicle) group.
Both biological and statistical significance were considered together.
Results and discussion
- Positive control results:
- In the periodic positive control experiment with alpha-Hexylcinnamaldehyde performed in May 2011 the EC3 (= estimated concentration for a S.I. of 3) was calculated to be 10.4 %.
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Value:
- 1
- Test group / Remarks:
- 0%
- Remarks on result:
- other: negative control
- Parameter:
- SI
- Value:
- 2.07
- Test group / Remarks:
- 25%
- Parameter:
- SI
- Value:
- 4.36
- Test group / Remarks:
- 50%
- Parameter:
- SI
- Value:
- 2.91
- Test group / Remarks:
- 100%
Any other information on results incl. tables
Viability / Mortality:
No deaths occurred during the study period.
Clinical Signs:
The animals did not show any signs of systemic toxicity or local skin irritation during the course of the study
Body Weights:
The body weight of the animals, recorded prior to the first application and prior to treatment with 3HTdR, was within the range commonly recorded for animals of this strain and age.
Lymph Node Weights and Cell Counts:
The measured lymph node weights and -cell counts of all animals treated were recorded after sacrifice.
A statistically significant increase in lymph node weight was observed at all tested concentrations (25, 50, and 100%) in comparison to the vehicle control group (p<0.05).
For BALB/c mice, a cut off-value for the lymph node cell count index of 1.55 was reported for a positive response. The index determined for the high dose group (1.53) was close, the index determined for the mid dose group (1.89) exceeded this threshold. A statistically significant increase in lymph node cell count was not observed in comparison to the vehicle control group.
Ear Weights:
The measured ear weights of all animals treated were recorded after sacrifice. A statistically significant increase in ear weight was observed for the mid and high dose group (50 and 100 %) in comparison to the vehicle control group.
For BALB/c mice, a threshold for the ear weight index of 1.1 was reported for a positive response. The ear weight indices determined for 50 and 100% were both slightly above this threshold (with indices of 1.19, each), indicating the presence of local skin irritation. The ear weight index determined for the lowest dose group (1.1) indicates a borderline positive response regarding ear skin irritation. However, the measured percentage of increase in ear weight (10.2 %, 18.8 %, and 18.6 %, at the low, mid and high dose, respectively) did not exceed the threshold value of 25 % for excessive local skin irritation.
Applicant's summary and conclusion
- Interpretation of results:
- sensitising
- Conclusions:
- In this study Stimulation Indices (S.I.) of 2.07, 4.36, and 2.91 were determined with the test item at concentrations of 25, 50% (v/v) in acetone:olive oil (4+1 v/v), and 100% (undiluted test item), respectively, and an EC3 value of 35.2% (v/v) was calculated. The test item showed an unusual dose-response relationship with a decreased S.I. at the highest tested concentration (100% of the undiluted test item) that might be due to different properties of the undiluted test item and the test item solution in acetone:olive oil (4+1 v/v) , e.g. immunosupression when applied undiluted.. On the basis of the present data, the test item has to be classified as a sensitiser.
- Executive summary:
It is concluded that N-formylmorpholine exhibit a skin sensitizing potential in the Murine Local Lymph Node Assay under the test conditions chosen and should be classified as a sensitiser according to Regulation 1272/2008/EC (GHS cat. 1B). (BASF, 2011)
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.